Feed CANF
Summary
30 / 100 · Bulios Score
Valuation 63Growth 15Profitability 20Quality 1Debt 69Stability 20
What speaks for it
- It holds more cash than debt: $2.99M against $49.0K.
- The price moves less than the market (beta 0.02).
What to watch
- Revenue fell by 20% a year over the last 3 years.
- The company made a loss over the last 12 months.
- It passes only 3 of the 9 points of the Piotroski financial health test.
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
2021202220232024202520262027
Diluted EPS (USD)
2021202220232024202520262027
- Analyst estimate
Revenue fell by 12% a year over 5 years. Over the last 3 years it fell by 20% a year.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $7.04M
Debt $49.0K
It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 3
- Hold 1
- Sell 0
Today's price within the analysts' price targets
Today's price $1.87 Average target $8
$1.87 $8
The average target of $8 is 328% above today's price. 75% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.